EUVIMEDEUVIMED entdecken
Crossref

Piperazine-Derived Diamine Lipid Nanoparticles Targeting to the Liver for Delivering Clustered Regularly Interspaced Short Palindromic Repeat Editing of PCSK9 to Durably Maintain Plasmatic Low-Density Lipoprotein Cholesterol in Low Levels

Shifeng Zhao, Shiyun Huang iD, Nan Li, Neng Wang, Zhitao Yu, Xiaoyu Liang, Zhenhuang Yang iD, Hongchang Guo

ACS Applied Bio Materials · 2026

DOI: 10.1021/acsabm.6c00032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Shifeng Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Nanoparticles, Liver, Gene Editing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Entrepreneurship Subsidy for Overseas Professionals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proprotein Convertase 9NanoparticlesLiverGene EditingCholesterol, LDLBiocompatible MaterialsLipidsPiperazineAnimalsHumansMiceMaterials TestingParticle SizeCRISPR-Cas SystemsMice, Inbred C57BL

Stichwörter der Autor:innen

CRISPR/Cas9 gene editingPCSK9lipid nanoparticlesliver-targeted deliverylow-density lipoprotein cholesterol

Substanzen

Proprotein Convertase 9Cholesterol, LDLBiocompatible MaterialsLipidsPiperazinePcsk9 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
  • Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China.
  • Edibeck Therapeutics, Shenzhen 518107, China.
  • MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, Zhejiang Province 310058, PR China.
  • State Key Laboratory of Transvascular Implantation Devices, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 311202, PR China.
  • Transvascular Implantation Devices Research Institute China, Hangzhou, Zhejiang Province 310053, PR China.

ORCID-Profile: Shiyun Huang, Zhenhuang Yang

Förderung

  • National Natural Science Foundation of China
  • Shenzhen Entrepreneurship Subsidy for Overseas Professionals

Zitieren

APA

Zhao, S., Huang, S., Li, N., Wang, N., Yu, Z., Liang, X., Yang, Z., & Guo, H. (2026). Piperazine-Derived Diamine Lipid Nanoparticles Targeting to the Liver for Delivering Clustered Regularly Interspaced Short Palindromic Repeat Editing of PCSK9 to Durably Maintain Plasmatic Low-Density Lipoprotein Cholesterol in Low Levels. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00032

Vancouver

Zhao S, Huang S, Li N, Wang N, Yu Z, Liang X, et al. Piperazine-Derived Diamine Lipid Nanoparticles Targeting to the Liver for Delivering Clustered Regularly Interspaced Short Palindromic Repeat Editing of PCSK9 to Durably Maintain Plasmatic Low-Density Lipoprotein Cholesterol in Low Levels. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00032

BibTeX
@article{Zhao2026,
  author = {Zhao, Shifeng and Huang, Shiyun and Li, Nan and Wang, Neng and Yu, Zhitao and Liang, Xiaoyu and Yang, Zhenhuang and Guo, Hongchang},
  title = {Piperazine-Derived Diamine Lipid Nanoparticles Targeting to the Liver for Delivering Clustered Regularly Interspaced Short Palindromic Repeat Editing of PCSK9 to Durably Maintain Plasmatic Low-Density Lipoprotein Cholesterol in Low Levels},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c00032}
}
Kostenlos starten →